An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure Chamber
Clinical trial NCT00537355 · COMPLETED
Trial details
- NCT number
- NCT00537355
- Sponsor
- Dynavax Technologies Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-03-01
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.